Navigation Links
Progen Pharmaceuticals Announces Fiscal 2007 Financial Results
Date:8/23/2007

- Positive Phase 2 Clinical Trial Results from PI-88 in Liver Cancer and

$92.4 million in Raised Capital Highlight the Year -

SYDNEY, Australia, Aug. 23 /PRNewswire-FirstCall/ -- Progen Pharmaceuticals Limited (ASX: PGL; Nasdaq: PGLA) today released its financial results for the fiscal year ended 30 June 2007.

Fiscal 2007 Corporate Highlights

* Announced positive results from a Phase 2, 172 patient, post-resection

liver cancer trial for P1-88 that support moving into a multi-national

registration-directed Phase 3 trial;

* Raised a net total of $92.4 million through various fundraising

activities, which provides Progen with additional working capital to fund

the Phase 3 clinical development of PI-88 in post-resection liver cancer,

conduct additional clinical trials of PI-88 in other indications and

further develop other product candidates;

* Completed a royalty-buy-back negotiation with Medigen Biotechnology

Corporation (Medigen) resulting in the conclusion of the Strategic

Alliance between the two companies, which provides Progen with maximum

flexibility and the opportunity to more rapidly develop and commercialise

PI-88;

* Continued efforts on the Company's Phase 2 PI-88 prostate and melanoma

trials with results expected in the first half and second half of calendar

2008, respectively;

* Completed Phase 2 Non-Small Cell Lung Cancer trial with results due by

the end of the third quarter in calendar 2007;

* Received a grant of up to $4.6 million through the Australian

Government's Pharmaceuticals Partnerships Program that will be used

towards PI-88's research and development costs;

* Expanded senior management team and established leading international

clinical advisory board of liver cancer specialists to support the

clinical development and commercialisation of PI-88 in post-resection<
'/>"/>

SOURCE Progen Pharmaceuticals Limited
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Progenics and Wyeth Announce Positive Results from Three-Month Clinical-Extension Study of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness
2. Progenics Announces Positive Results in Clinical Trial of Novel HIV Therapy
3. Progens Phase 2 Liver Cancer Trial Exceeds Efficacy Objective
4. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
10. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... , July 30, 2014  Decision Resources ... preclinical animal research imaging system market ... multimodality imaging, such as combining computed tomography and ... imaging. This demand stems from the need for ... among scientific journals, which will spur preclinical imaging ...
(Date:7/30/2014)... WESTFORD, Mass. , July 30, 2014 ... in laser- and light-based aesthetic treatments for non-invasive and minimally ... promoted Executive Vice President, Chief Operating Officer and Chief Financial ... Company, effective August 1, 2014.  Baker, 53, will continue to ... from Michael Davin , who remains Chairman and Chief ...
(Date:7/30/2014)... PHILADELPHIA , July 30, 2014  Packaging Coordinators, ... a definitive agreement to acquire Penn Pharmaceutical Services Limited ... Wales in the United Kingdom ... New Hope, Pennsylvania and Tokyo ... manufacturing services, including Clinical and Commercial dosage form manufacturing, ...
Breaking Medicine Technology:Growing Popularity of Multimodality Imaging Will Drive the Preclinical Animal Research Imaging System Market 2Cynosure Appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President 2PCI Announces Definitive Agreement to Acquire Penn Pharma 2PCI Announces Definitive Agreement to Acquire Penn Pharma 3PCI Announces Definitive Agreement to Acquire Penn Pharma 4PCI Announces Definitive Agreement to Acquire Penn Pharma 5
... AVENTURA, Fla., Aug. 15, 2011 Double Eagle ... has retained National Securities Corporation as the ... round of capitalization, as well as possible acquisition and ... company of Fuse Science, Inc. ( www.fusescience.com ), the ...
... MINNETONKA, Minn., Aug. 15, 2011 Uroplasty, Inc. (Nasdaq: ... develops, manufactures and markets innovative proprietary products to treat ... clinical studies using Uroplasty,s Urgent® PC Neuromodulation System are ... meeting, August 29-September 2, 2011 in Glasgow, Scotland.   ...
Cached Medicine Technology:Double Eagle Holdings Chooses National Securities Corporation as Exclusive Investment Banker 2Urgent® PC Clinical Studies Results Scheduled for Presentation at International Continence Society 2Urgent® PC Clinical Studies Results Scheduled for Presentation at International Continence Society 3
(Date:7/31/2014)... Eagle, Colorado (PRWEB) July 31, 2014 ... Challenge returns to Colorado’s Gore Range September 12-14, ... multi-sport, multi-team adventure race features teams of disabled and ... described as one of America’s most challenging by experienced ... del Rio fishing resort along the Colorado River ...
(Date:7/31/2014)... City, NY (PRWEB) July 31, 2014 ... chocolate , will be available in New York's favorite ... in August. BRC is known for their commitment to ... Associated Press. , Chocolatto® is the new sensation from ... hot chocolate ! A delicious highly popular Italian dessert ...
(Date:7/31/2014)... July 31, 2014 Nuanced Media, a ... launch of the Nuanced Medical website . Nuanced ... the needs of the Medical Industry. , The idea ... services for medical practices to meet continuously changing federal ... the HIPAA Act (Health Insurance Portability and Accountability Act), ...
(Date:7/30/2014)... Ohio (PRWEB) July 31, 2014 CareSource, ... Douglas A. Fecher President and CEO, Wright-Patt Credit Union, ... Fecher, is a foremost financial CEO with an extensive ... president of lending and later chief operating officer at ... Fecher has led the Beavercreek-based Wright-Patt Credit Union that ...
(Date:7/30/2014)... 31, 2014 Regardless of traumatic events experienced during ... develop a drinking problem if faced with civilian life ... financial and legal problems all commonplace in military ... University,s Mailman School of Public Health are published online ... , Alcohol abuse is a major concern for reservists ...
Breaking Medicine News(10 mins):Health News:World T.E.A.M. Sports’ Adventure Team Challenge Returns to Colorado’s High Country 2Health News:World T.E.A.M. Sports’ Adventure Team Challenge Returns to Colorado’s High Country 3Health News:Dolce Vite Chocolatto® - World's Best Thick Dark Italian Hot Chocolate Now Available at NYC's Favorite Cafe Brooklyn Roasting Company 2Health News:Nuanced Media, HIPAA Certified Agency, Launches Medical Web Design Service Website 2Health News:Veterans' alcohol problems linked to stress on the home front 2
... ... 1980,s and is now a major health concern with no known cure. The causes of ... , ... -- Following remarkable improvement in the condition of children who have received this stem cell ...
... ... ... -- LML Music announces the April 13, 2010 release of , in my ... room, was conceived and produced by LML recording artist D.C. Anderson , the prolific ...
... ... and introduces new, ,Band Aid, versions of common cosmetic surgery procedures. , ... (Vocus) April 13, 2010 -- Atlanta Plastic ... Aid Lipo, – a less invasive, more cost effective mini liposuction procedure. Similar to ...
... ... suffering from keratoconus , ... April 12, 2010 -- Khanna Institute will now be offering Intacs of 400 ... Intacs corneal implants Addition Technology, Inc., that it has received FDA approval for an expanded ...
... ... the industry are faced with the daunting task to either establish or rethink their B2C ... more urgent by new government regulations, fees and taxes, and ever-present competitive factors that will ... ...
... ERs for help rather than a doctor,s office, study finds ... uninsured or who are on Medicaid are much less likely ... have private coverage. , In fact, more than 5.5 million ... their migraines because of their insurance status, a new study ...
Cached Medicine News:Health News:Thanks to a New Stem Cell Therapy, a 9-year Old Autistic Boy Talks to his Father for the First Time 2Health News:Thanks to a New Stem Cell Therapy, a 9-year Old Autistic Boy Talks to his Father for the First Time 3Health News:Thanks to a New Stem Cell Therapy, a 9-year Old Autistic Boy Talks to his Father for the First Time 4Health News:Peter Bradley Adams, Victoria Shaw, Many Distinguished Colleagues Ally To Benefit National MS Society With CD Release: In My Room 2Health News:Peter Bradley Adams, Victoria Shaw, Many Distinguished Colleagues Ally To Benefit National MS Society With CD Release: In My Room 3Health News:Peter Bradley Adams, Victoria Shaw, Many Distinguished Colleagues Ally To Benefit National MS Society With CD Release: In My Room 4Health News:Atlanta Plastic Surgeon Dr. John LeRoy Expands on Success of 'Band-Aid Facelift' to Offer 'Band Aid Lipo' 2Health News:Atlanta Plastic Surgeon Dr. John LeRoy Expands on Success of 'Band-Aid Facelift' to Offer 'Band Aid Lipo' 3Health News:Khanna Institute to Offer Newly FDA Approved Expanded Range of Intacs for Keratoconus 2Health News:Khanna Institute to Offer Newly FDA Approved Expanded Range of Intacs for Keratoconus 3Health News:ConnextionsHealth Poised to Help Organizations Leverage Revenue-Driving Opportunities Related to Health Reform 2Health News:ConnextionsHealth Poised to Help Organizations Leverage Revenue-Driving Opportunities Related to Health Reform 3Health News:Finding Good Migraine Care a Headache for the Uninsured 2Health News:Finding Good Migraine Care a Headache for the Uninsured 3
Semi-Automated Chemistry Analyzer with model screen master. The Screen Master incorporates many powerful features in one compact unit. Useful for biochemical investigations, enzymatic, immunoturbidi...
... Geometric Data Hemastainer. Formulated to ... quality control tested on human ... staining and absence of precipitate. ... a minimum of eight hours ...
... Unique molecular suspension in methanol for ... chromosome, and histology smears. Our special ... rapidly penetrates cellular elements producing unequaled ... detail and unexcelled brilliance in the ...
Wright-Giemsa Stain Solutions...
Medicine Products: